Literature DB >> 23564368

Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report.

Wade Iams1, Kathyrn Eby Beckermann, Anne T Neff, Ingrid A Mayer, Vandana Gupta Abramson.   

Abstract

Chemotherapy-induced thrombotic microangiopathy is a severe illness that has occurred in a small number of patients treated with carboplatin and combination of docetaxel and trastuzumab chemotherapy. We describe herein the case of a patient with stage IIB breast cancer who developed thrombotic microangiopathy after five cycles of carboplatin, docetaxel, and trastuzumab.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23564368      PMCID： PMC3774143          DOI： 10.1007/s12032-013-0568-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  13 in total

Review 1.  Thrombotic microangiopathies.

Authors:  Joel L Moake
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

Review 2.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab.

Authors:  Adedayo A Onitilo; Jessica M Engel; Lawrence H Clouse; Kristin M Gerndt
Journal:  J Vasc Interv Radiol       Date:  2008-12-03       Impact factor: 3.464

4.  Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy).

Authors:  W S SYMMERS
Journal:  Br Med J       Date:  1952-10-25

Review 5.  Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases.

Authors:  Klaus Lechner; Hanna Lena Obermeier
Journal:  Medicine (Baltimore)       Date:  2012-07       Impact factor: 1.889

Review 6.  Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review.

Authors:  Jeffrey S Dlott; Constance F M Danielson; Deborah E Blue-Hnidy; Leo J McCarthy
Journal:  Ther Apher Dial       Date:  2004-04       Impact factor: 1.762

Review 7.  Thrombotic microangiopathy associated with chemotherapy: case report and review of the literature.

Authors:  S M Fields; C M Lindley
Journal:  DICP       Date:  1989 Jul-Aug

8.  Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.

Authors:  D C Fisher; G B Sherrill; A Hussein; P Rubin; J J Vredenburgh; M Elkordy; M Ross; W Petros; W P Peters
Journal:  Bone Marrow Transplant       Date:  1996-07       Impact factor: 5.483

9.  Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: a case report.

Authors:  Keith Siau; Mohini Varughese
Journal:  Med Oncol       Date:  2009-10-22       Impact factor: 3.064

10.  Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.

Authors:  J E Cantrell; T M Phillips; P S Schein
Journal:  J Clin Oncol       Date:  1985-05       Impact factor: 44.544
View more
  2 in total

1.  Thrombotic thrombocytopenic purpura following salvage chemotherapy with paclitaxel, ifosfamide and cisplatin in a patient with a refractory germ cell tumor: A case report and review of the literature.

Authors:  Arife Ulas; Kamile Silay; Sema Akinci; Muhammed Bulent Akinci; Mehmet Ali Sendur; Didem Sener Dede; Yunus Halil Polat; Bulent Yalcin
Journal:  Oncol Lett       Date:  2015-06-08       Impact factor: 2.967

2.  Hemophagocytic syndrome with histiocytic glomerulopathy associated with ovarian serous carcinoma.

Authors:  Wesley Hiser; Michael Landgarten; Xin Jin Zhou
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.